Book an appointment with us, or search the directory to find the right lawyer for you directly through the app.
Find out moreWelcome to the first edition of Law Update for 2025. As we begin this exciting year, we are pleased to turn our attention to one of the most dynamic sectors in the UAE and the broader GCC region – healthcare. Over the past several years, the region has seen unprecedented growth in this sector, driven by legislative advancements, technological innovations, and the increasing focus on sustainability and AI. As such, healthcare is set to be one of the most important sectors in the coming decade.
In this issue, we explore key themes that are significantly shaping the future of healthcare in the UAE, such as recent changes in foreign ownership laws. These reforms present a major opportunity for foreign investors, opening up new avenues for international collaborations and improving the overall healthcare infrastructure. The changes in ownership laws are an important milestone, and we provide an analysis of what this means for the industry and the various players involved.
Read Now2025 is set to be a game-changer for the MENA region, with legal and regulatory shifts from 2024 continuing to reshape its economic landscape. Saudi Arabia, the UAE, Egypt, Iraq, Qatar, and Bahrain are all implementing groundbreaking reforms in sustainable financing, investment laws, labor regulations, and dispute resolution. As the region positions itself for deeper global integration, businesses must adapt to a rapidly evolving legal environment.
Our Eyes on 2025 publication provides essential insights and practical guidance on the key legal updates shaping the year ahead—equipping you with the knowledge to stay ahead in this dynamic market.
Kuwait’s Ministry of Health (“MOH”) issued Resolution No. 100 of 2023 in April 2023 (“Resolution 100/2023”). Resolution 100/2023 repeals a previous MOH resolution from 2022, which regulated the mechanism for importing non-registered medicines and pharmaceutical products. Further, it adds a new article to Resolution No. 361 of 2019. The new article allows for medicines used in the diagnosis, treatment, or prevention of diseases and registered with international supervisory authorities without any alternative replacements available, to be registered at the request of authorities at the Ministry of Health. This will be done in accordance with the requirements set out by the Department for the Registration and Control of Medical and Plant Based Medicines at the Ministry of Health.
Al Tamimi & Company are able assist in ensuring compliance with the evolving Ministry of Health Resolutions in Kuwait.
To learn more about our services and get the latest legal insights from across the Middle East and North Africa region, click on the link below.